-
Valdecoxib is a
nonsteroidal anti-inflammatory drug (NSAID) used in the
treatment of osteoarthritis,
rheumatoid arthritis, and
painful menstruation and...
- name
Dynastat among others, is a water-soluble and
injectable prodrug of
valdecoxib.
Parecoxib is a COX2
selective inhibitor. It is injectable. It is approved...
-
launched in May 1999.
Celecoxib and
other COX-2
selective inhibitors,
valdecoxib, parecoxib, and mavacoxib, were
discovered by a team at the
Searle division...
-
celecoxib (Celebrex)
being the
least COX-2 selective, and
rofecoxib (Vioxx),
valdecoxib (Bextra), and
etoricoxib (Arcoxia),
being highly COX-2 selective. At the...
- Celecoxib (+tramadol)
Etoricoxib Lumiracoxib ‡
Parecoxib Rofecoxib ‡
Valdecoxib ‡
Fenamates Flufenamic acid
Meclofenamic acid
Mefenamic acid Tolfenamic...
- acid
Etofenamate Celecoxib (FDA alert)
Rofecoxib (withdrawn from market)
Valdecoxib (withdrawn from market)
Parecoxib FDA withdrawn,
licensed in the EU Lumiracoxib...
-
Trazodone Triclofos Trifluoperazine Trifluperidol Trimipramine Troglitazone Valdecoxib Sodium valproate Venlafaxine Veralipride Vigabatrin Vilazodone Vortioxetine...
- Celecoxib (+tramadol)
Etoricoxib Lumiracoxib ‡
Parecoxib Rofecoxib ‡
Valdecoxib ‡
Fenamates Flufenamic acid
Meclofenamic acid
Mefenamic acid Tolfenamic...
-
events by 40% on average. This led to the
withdrawal of
rofecoxib and
valdecoxib, and
warnings on others.
Etoricoxib seems relatively safe, with the risk...
-
clinical practice meloxicam can
still cause some
ulcer complications.
Valdecoxib and
rofecoxib were
about 300
times more
potent at
inhibiting COX-2 than...
